Cumberland Pharmaceuticals (CPIX) Minority Interest (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Minority Interest of -$333512.0 for Q1 2026, up 0.77% sequentially from -$336100.0 in Q4 2025, and down 5.41% YoY from -$352579.5 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Minority Interest (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Minority Interest for 17 years, with the latest figure at -$333512.0 in Q1 2026.
- Quarterly Minority Interest fell 5.41% year-over-year to -$333512.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$333512.0 (down 5.41% YoY) and the FY2025 annual result came in at -$336100.0, down 9.29% from the prior year.
- Minority Interest improved to -$333512.0 in Q1 2026 per CPIX's latest filing, from -$336100.0 in the prior quarter.
- Over five years, Minority Interest peaked at -$229508.0 in Q1 2022 and troughed at -$343572.0 in Q4 2023.
- A 5-year average of -$306871.5 and a median of -$312024.0 in 2023 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2022 and 2024: Minority Interest tumbled 79.11% in 2022, then grew 10.49% in 2024.
- Over 5 years, Minority Interest stood at -$292126.0 in 2022, then fell by 17.61% to -$343572.0 in 2023, then rose by 10.49% to -$307517.0 in 2024, then dropped by 9.29% to -$336100.0 in 2025, then increased by 0.77% to -$333512.0 in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered -$333512.0, -$336100.0, and -$319150.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Cumberland Pharmaceuticals | 117.01 Mn | 113.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -331,565.00 |
| Mar 31, 2026 | -333,512.00 |
| Dec 31, 2025 | -336,100.00 |
| Sep 30, 2025 | -319,150.00 |
| Jun 30, 2025 | -310,868.00 |
| Mar 31, 2025 | -316,401.00 |
| Dec 31, 2024 | -307,517.00 |
| Sep 30, 2024 | -309,694.00 |
| Jun 30, 2024 | -316,806.00 |
| Mar 31, 2024 | -299,781.00 |
| Dec 31, 2023 | -343,572.00 |
| Sep 30, 2023 | -335,991.00 |
| Jun 30, 2023 | -322,070.00 |
| Mar 31, 2023 | -312,024.00 |
| Dec 31, 2022 | -292,126.00 |
| Sep 30, 2022 | -273,141.00 |
| Jun 30, 2022 | -258,554.00 |
| Mar 31, 2022 | -229,508.00 |
| Dec 31, 2021 | -212,328.00 |
| Sep 30, 2021 | -175,767.00 |